Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Moderna & Pfizer

15 shared events · Importance 4 · Last updated Sep 03, 2026

Importance
4
Shared Events
15
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
70
Regulatory
Moderna: Moderna, a key player in mRNA vaccines, is likely to see increased investor confidence and market opportunities following the FDA's approval of an mRNA flu vaccine.
Pfizer: Pfizer, a leader in mRNA COVID-19 vaccines, benefits from the broader acceptance of mRNA technology, though the specific flu vaccine approval is not attributed to them.
Aug 06, 2026 · 6 articles
69
Domestic
Moderna: Received FDA approval for its mRNA flu vaccine mFlusiva, which showed 27% higher efficacy; expects doses in pharmacies soon, potentially boosting revenue.
Pfizer: Offers COVID-19 vaccines; benefits from continued recommendations and potential increased uptake.
Sep 02, 2026 · 20 articles
55
Regulatory
Moderna: Moderna received its fourth FDA-approved product and first mRNA flu vaccine, boosting its commercial prospects and validating its mRNA platform.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
45
Business
Moderna: Moderna secured a major supply contract with the International — European Commission for its RSV vaccine, enhancing its commercial prospects and competitive position against GSK and Pfizer.
Pfizer: Pfizer's RSV vaccine Abrysvo faces increased competition from Moderna's mRESVIA in the EU market.
Jul 09, 2026 · 6 articles
45
Tech
Moderna: Moderna is the co-developer of the vaccine and the primary beneficiary, with its stock more than doubling and market cap surging by nearly $40 billion. The trial success validates its mRNA platform and could lead to its entry into the cancer drug market, helping offset declining COVID-19 vaccine sales.
Pfizer: Pfizer, a partner of BioNTech, may benefit indirectly from the validation of mRNA technology in cancer treatment.
Aug 19, 2026 · 126 articles
30
Domestic
Moderna: One of the vaccine manufacturers; similar to Pfizer, minimal direct impact.
Pfizer: One of the vaccine manufacturers; the controversy may slightly affect public perception, but no direct impact.
Aug 06, 2026 · 17 articles
20
Business
Moderna: Moderna co-founder Robert S. Langer's involvement as an advisor links the company to Chiron, but Moderna itself is not directly affected.
Pfizer: Former Pfizer CMO Freda Lewis-Hall's advisory role provides a connection to Pfizer, but Pfizer itself is not directly affected.
Jul 22, 2026 · 6 articles
15
Tech
Moderna: Moderna is mentioned only because some Phase I participants had previously received Moderna COVID-19 mRNA vaccines, positioning it as a potential beneficiary of AdJane's mucosal booster concept. The event has no material effect on Moderna's business or outlook.
Pfizer: Pfizer is mentioned only because some Phase I participants had previously received Pfizer COVID-19 mRNA vaccines, making it a potential target for AdJane's complementary mucosal booster approach. The event has no material effect on Pfizer's business or outlook.
Sep 10, 2026 · 9 articles
10
Business
Moderna: Moderna is a partner with Vertex in developing CF treatments for patients not covered by Vertex's CFTR modulators. The acquisition does not directly affect Moderna.
Pfizer: Competitor in acromegaly market; PALSONIFY may compete with its treatments.
Jul 06, 2026 · 34 articles
10
Business
Moderna: Moderna is mentioned as an existing AWS customer, but this event does not directly impact it.
Pfizer: Pfizer is mentioned as an existing AWS customer, but this event does not directly impact it.
Aug 10, 2026 · 7 articles
0
Regulatory
Moderna: Moderna is another pharmaceutical company that entered into advance purchase agreements with the International — European Commission, also mentioned in the context of the secret vaccine deals.
Jun 11, 2026 · 7 articles
0
Domestic
Moderna: Moderna is named as a donor to Vaccinate Your Family, indicating its financial support for pro-vaccine advocacy, which indirectly benefits its vaccine business.
May 18, 2026 · 7 articles
0
Business
Apr 01, 2026 · 6 articles
0
Domestic
Mar 16, 2026 · 22 articles
0
Domestic
Apr 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Moderna and Pfizer interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.